| Cell line name |
1.18 |
|---|
| Accession |
CVCL_C8GI |
|---|
| Resource Identification Initiative |
To cite this cell line use: 1.18 (RRID:CVCL_C8GI) |
|---|
| Comments |
From: Jaffee, Elizabeth Marion; Johns Hopkins University School of Medicine; Baltimore; USA.
Derived from site: In situ; Kidney; UBERON=UBERON_0002113. |
|---|
| HLA typing |
Source: PubMed=15585611
| Class I | | HLA-A | A*01,24 | | HLA-B | B*07,08 | | HLA-C | C*07 |
|
|---|
| Disease |
Renal cell carcinoma (NCIt: C9385)
Renal cell carcinoma (ORDO: Orphanet_217071) |
|---|
| Species of origin |
Homo sapiens (Human)
(NCBI Taxonomy: 9606) |
|---|
| Sex of cell |
Sex unspecified |
|---|
| Age at sampling |
Age unspecified |
|---|
| Category |
Cancer cell line |
|---|
| Publications | PubMed=15585611; DOI=10.1158/1078-0432.CCR-04-0072
Scott Simon Tykodi, Edus Houston Warren, John A. Thompson, Stanley R. Riddell, Richard W. Childs, Brith E. Otterud, Mark F. Leppert, Rainer Storb, Brenda M. Sandmaier;
Allogeneic hematopoietic cell transplantation for metastatic renal cell carcinoma after nonmyeloablative conditioning: toxicity, clinical response, and immunological response to minor histocompatibility antigens.
Clin. Cancer Res. 10:7799-7811(2004) PubMed=18698046; DOI=10.1158/1078-0432.CCR-08-0028; PMCID=PMC2693478
Scott Simon Tykodi, Nobuharu Fujii, Nathalie Vigneron, Sharon M. Lu, Jeffrey K. Mito, Maureen X. Miranda, Jeffrey Chou, Lilien N. Voong, John A. Thompson, Brenda M. Sandmaier, Peter Cresswell ...Show all 14 authors... , Benoit J. van den Eynde, Stanley R. Riddell, Edus Houston Warren; Show fewer authors
C19orf48 encodes a minor histocompatibility antigen recognized by CD8+ cytotoxic T cells from renal cell carcinoma patients.
Clin. Cancer Res. 14:5260-5269(2008) |
|---|
| Cross-references |
|---|
| Encyclopedic resources |
Wikidata; Q123030193
|
|---|
| Entry history |
|---|
| Entry creation | 05-Oct-2023 |
|---|
| Last entry update | 10-Sep-2024 |
|---|
| Version number | 3 |
|---|
